NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

Shuttle Pharmaceuticals logo
$4.61 +0.37 (+8.73%)
As of 03:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Advanced

Key Stats

Today's Range
$3.61
▼
$4.24
50-Day Range
$3.13
▼
$5.59
52-Week Range
$2.58
▼
$44.40
Volume
42,595 shs
Average Volume
722,862 shs
Market Capitalization
$21.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing treatments intended to improve outcomes for patients receiving radiation therapy for cancer. The company is based in Rockville, Maryland.

Its lead drug candidate, ropidoxuridine, is an oral prodrug designed to make cancer cells more sensitive to radiation. Shuttle has studied the candidate in combination with radiation therapy, including for patients with glioblastoma, an aggressive form of brain cancer.

The company’s research also includes developing personalized cancer treatments and other drug candidates intended to enhance the effects of radiation. Its work is primarily focused on cancer treatment research and development.

AI Generated. May Contain Errors.

Shuttle Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

SHPH MarketRank™: 
1.221470276005 of 5 stars

Shuttle Pharmaceuticals scored higher than 24% of companies evaluated by MarketBeat, and ranked 496th out of 585 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Shuttle Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Shuttle Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

  • Read more about Shuttle Pharmaceuticals' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shuttle Pharmaceuticals is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shuttle Pharmaceuticals is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Shuttle Pharmaceuticals has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.31% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.54, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 52.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Shuttle Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Shuttle Pharmaceuticals does not have a long track record of dividend growth.

  • News Sentiment

    Shuttle Pharmaceuticals has a news sentiment score of 1.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Shuttle Pharmaceuticals this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Shuttle Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Shuttle Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.36% of the stock of Shuttle Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    4.58% of the stock of Shuttle Pharmaceuticals is held by institutions.

  • Read more about Shuttle Pharmaceuticals' insider trading history.
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SHPH Stock News Headlines

“IMPERIUM”: The #1 investment of 2027
Could a strange new bio-chip be the most transformative innovation in history? Elon Musk calls it "amazing." A NASA scientist says it's "bigger than AI." A Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money & Markets, calls the technology Imperium. He says it's set to spark a major investment megatrend, with one small Silicon Valley company at the center.tc pixel
SHPH Share News Today
See More Headlines

SHPH Stock Analysis - Frequently Asked Questions

Shuttle Pharmaceuticals' stock was trading at $18.00 on January 1st, 2026. Since then, SHPH shares have decreased by 78.0% and is now trading at $3.9550.

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($75.00) earnings per share (EPS) for the quarter.

Shuttle Pharmaceuticals shares reverse split on Thursday, June 11th 2026.The 1-10 reverse split was announced on Tuesday, June 9th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 10th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shuttle Pharmaceuticals (SHPH) raised $10 million in an initial public offering on Tuesday, August 30th 2022. The company issued 1,225,888 shares at a price of $8.13 per share.

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shuttle Pharmaceuticals investors own include NVIDIA (NVDA), Tesla (TSLA), Applied Digital (APLD), AST SpaceMobile (ASTS), Intel (INTC), Micron Technology (MU) and BigBear.ai (BBAI).

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Software
Sub-Industry
Application Software
Current Symbol
NASDAQ:SHPH
CIK
1757499
Fax
N/A
Employees
2
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
($18.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.72 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-168.34%
Return on Assets
-90.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$11.14 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
4,760,000
Free Float
4,748,000
Market Cap
$18.04 million
Optionable
Not Optionable
Beta
-0.04

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:SHPH) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners